US lawmakers hammer FDA Chief Hamburg over compounding lapses
This article was originally published in SRA
Executive Summary
US Food and Drug Administration Commissioner Margaret Hamburg faced a dizzying amount of rapid-fire questions during a 16 April House of Representatives hearing about why regulators had failed to prevent a fungal meningitis outbreak that was triggered by tainted compounded drugs, causing 733 Americans in 20 states to fall ill and killing 531-3.